ClinicalTrials.Veeva

Menu

Digital Cervical and Cesarean Section

A

Assiut University

Status

Completed

Conditions

Caesarean Section

Treatments

Other: No cervical dilatation
Procedure: Caesarean section
Other: cervical dilatation

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Cesarean delivery is one of the most commonly performed surgical operations worldwide Cesarean delivery even as an elective procedure has been associated with considerable maternal risks compared with vaginal delivery. Some of the complications include postpartum hemorrhage, uterine infection, urinary tract infection, wound infection, septicemia and maternal death. Over the years, many variations in the surgical technique of Cesarean delivery have been employed with the main purpose of improving its safety. A woman's cervix is firm and undilated at the beginning of pregnancy, but progressive remodeling occurs during gestation until the cervix is soft at term, especially the nulliparous cervix . The progressive dilatation of the cervix needs uterine contraction during labor. A mechanical dilatation of the cervix at cesarean section is defined as an artificial dilatation of the cervix performed by finger, sponge forceps or other instruments at non-labor cesarean section. According to a cochrane view The information currently available about the advantages of cervical dilatation at cesarean section is inconclusive. This may be due to small sample sizes and low power of statistic.

Enrollment

300 patients

Sex

Female

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. All women scheduled for elective cesarean section will be approached.
  2. Women accepted to participate in the study participation after discussing the nature of the study.

Exclusion criteria

  1. Immuno-compromised women.
  2. Women suffering from any coagulation disorder or Blood disease.
  3. Blood transfusion during surgery or before it.
  4. History of wound infection or endometritis .
  5. Ante partum hemorrhage.
  6. History of long corticosteroid use.
  7. Women refuse to participate in the study.
  8. Suspected clinical evidence of infection.
  9. anemic women
  10. Multiple pregnancy
  11. Preterm births
  12. Rupture of membranes or chorioamnionitis
  13. Women who use antibiotics during the last 24 hours due to any infection but not prophylactic antibiotic during caesarian section
  14. Emergency caesarean section

Trial design

300 participants in 2 patient groups

Group A: cervical dilatation
Description:
patients who will have cervical dilatation during Caesarean section
Treatment:
Procedure: Caesarean section
Other: cervical dilatation
Group A: non cervical dilatation
Description:
patients who will have not cervical dilatation during Caesarean section
Treatment:
Other: No cervical dilatation
Procedure: Caesarean section

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems